Panobinostat/Velcade in Multiple Myeloma

Share this content:

Panobinostat/Velcade in Multiple Myeloma

Sponsor and Collaborators     
University of Utah
Novartis

Contact    
Karen Pena     801-213-4233     karen.pena@hci.utah.edu
Leanne Lujan     801-587-4487     leanne.lujan@hci.utah.edu   

Investigator
Mauizio Zangari, MD     
University of Utah

ClinicalTrials.gov Identifier
NCT00891033

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs